• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺表面活性物质蛋白A和D与螨(屋尘螨)过敏原的相互作用。

Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.

作者信息

Wang J Y, Kishore U, Lim B L, Strong P, Reid K B

机构信息

Department of Biochemistry, University of Oxford, UK.

出版信息

Clin Exp Immunol. 1996 Nov;106(2):367-73. doi: 10.1046/j.1365-2249.1996.d01-838.x.

DOI:10.1046/j.1365-2249.1996.d01-838.x
PMID:8918587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2200585/
Abstract

Human lung surfactant proteins A (SP-A) and D (SP-D) are both collagenous C-type lectins which appear to mediate antimicrobial activity by binding to carbohydrates on micro-organisms and to receptors on phagocytic cells. Purified native SP-A and SP-D, isolated from human bronchoalveolar lavage fluid, were found to bind to whole mite extracts (Dermatophagoides pteronyssinus) and the purified allergen Der p I, in a carbohydrate-specific and calcium-dependent manner. Binding was inhibited by ethylenediamine tetra-acetic acid (EDTA) as well as by maltose in the case of SP-D, or mannose in the case of SP-A. A recombinant polypeptide, which trimerized to form the neck region and carbohydrate recognition domains of SP-D, also inhibited the binding of native SP-D to the whole mite extract and Der p I. Both SP-A and SP-D did not bind to deglycosylated whole mite extracts or to recombinant Der p proteins, which lacked carbohydrate residues. These results suggest that the ability of surfactant proteins to bind certain allergens is mediated through their carbohydrate-recognition domains (CRDs) interacting with carbohydrate residues on the allergens. Moreover, SP-A and SP-D were found to inhibit allergen-specific IgE binding to the mite extracts either via steric hindrance or competitive binding. It is therefore possible that SP-A and SP-D may be involved in the modulation of allergen sensitization and/or the development of allergic reactions.

摘要

人肺表面活性物质蛋白A(SP-A)和蛋白D(SP-D)均为胶原性C型凝集素,它们似乎通过与微生物上的碳水化合物以及吞噬细胞上的受体结合来介导抗菌活性。从人支气管肺泡灌洗液中分离出的纯化天然SP-A和SP-D,被发现以碳水化合物特异性和钙依赖性方式与全螨提取物(屋尘螨)和纯化的变应原Der p I结合。对于SP-D,乙二胺四乙酸(EDTA)以及麦芽糖可抑制结合;对于SP-A,甘露糖可抑制结合。一种三聚化形成SP-D颈部区域和碳水化合物识别结构域的重组多肽,也抑制天然SP-D与全螨提取物和Der p I的结合。SP-A和SP-D均不与去糖基化的全螨提取物或缺乏碳水化合物残基的重组Der p蛋白结合。这些结果表明,表面活性物质蛋白与某些变应原结合的能力是通过其碳水化合物识别结构域(CRD)与变应原上的碳水化合物残基相互作用来介导。此外,发现SP-A和SP-D可通过空间位阻或竞争性结合来抑制变应原特异性IgE与螨提取物的结合。因此,SP-A和SP-D可能参与变应原致敏的调节和/或过敏反应的发生。

相似文献

1
Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.人肺表面活性物质蛋白A和D与螨(屋尘螨)过敏原的相互作用。
Clin Exp Immunol. 1996 Nov;106(2):367-73. doi: 10.1046/j.1365-2249.1996.d01-838.x.
2
Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.肺表面活性蛋白A和D可抑制特异性IgE与烟曲霉过敏原的结合,并阻止过敏原诱导的人嗜碱性粒细胞组胺释放。
Clin Exp Immunol. 1997 Nov;110(2):241-9. doi: 10.1111/j.1365-2249.1997.tb08323.x.
3
Allergen-induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma.在小鼠哮喘模型中,变应原诱导的支气管炎症与表面活性蛋白A和D水平降低有关。
Clin Exp Allergy. 2001 Apr;31(4):652-62. doi: 10.1046/j.1365-2222.2001.01031.x.
4
Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D.主要屋尘螨过敏原——屋尘螨1和粉尘螨1可降解并使肺表面活性物质蛋白A和D失活。
J Biol Chem. 2007 Dec 21;282(51):36808-19. doi: 10.1074/jbc.M702336200. Epub 2007 Sep 11.
5
Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma.肺表面活性物质蛋白A和D对哮喘患儿变应原诱导的淋巴细胞增殖及组胺释放的抑制作用
Am J Respir Crit Care Med. 1998 Aug;158(2):510-8. doi: 10.1164/ajrccm.158.2.9709111.
6
Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein.表面活性蛋白D是一种二价阳离子依赖性碳水化合物结合蛋白。
J Biol Chem. 1990 Apr 5;265(10):5755-60.
7
Characterization of pulmonary surfactant protein D: its copurification with lipids.肺表面活性物质蛋白D的特性:其与脂质的共纯化
Biochim Biophys Acta. 1991 Nov 5;1086(2):185-90. doi: 10.1016/0005-2760(91)90006-4.
8
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule.清道夫受体超家族新成员糖蛋白-340(gp-340)作为肺表面活性物质蛋白-D结合分子的分离与鉴定。
J Biol Chem. 1997 May 23;272(21):13743-9. doi: 10.1074/jbc.272.21.13743.
9
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin.人肺表面活性物质相关蛋白A的碳水化合物结合特性研究及其与另外两种凝集素:甘露聚糖结合蛋白和胶固素的比较。
Biochem J. 1993 Aug 1;293 ( Pt 3)(Pt 3):873-8. doi: 10.1042/bj2930873.
10
Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A.表面活性蛋白D(SP-D)可抵消表面活性蛋白A(SP-A)对II型肺泡细胞磷脂分泌的抑制作用。天然SP-D与SP-A的相互作用。
Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):115-9. doi: 10.1042/bj2790115.

引用本文的文献

1
Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.重新审视表面活性蛋白D:一种连接固有免疫和适应性免疫的免疫监视分子。
Front Immunol. 2024 Dec 17;15:1491175. doi: 10.3389/fimmu.2024.1491175. eCollection 2024.
2
Immature Surfactant Protein Type B and Surfactant Protein Type D Correlate with Coronary Heart Disease in Patients with Type 2 Diabetes.未成熟的表面活性蛋白B和表面活性蛋白D与2型糖尿病患者的冠心病相关。
Life (Basel). 2024 Jul 17;14(7):886. doi: 10.3390/life14070886.
3
Allergic Rhinitis: A Clinical and Pathophysiological Overview.变应性鼻炎:临床与病理生理学概述
Front Med (Lausanne). 2022 Apr 7;9:874114. doi: 10.3389/fmed.2022.874114. eCollection 2022.
4
Pulmonary Surfactants: a New Therapeutic Target in Asthma.肺表面活性剂:哮喘治疗的新靶点。
Curr Allergy Asthma Rep. 2020 Sep 11;20(11):70. doi: 10.1007/s11882-020-00968-8.
5
Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells.肿瘤微环境中的透明质酸可抵消重组人表面活性蛋白 D 片段对乳腺癌细胞的促凋亡作用。
Front Immunol. 2020 Jul 8;11:1171. doi: 10.3389/fimmu.2020.01171. eCollection 2020.
6
Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces.可溶性模式识别分子:气道黏膜表面稳态的守护者和调节剂。
Eur J Immunol. 2020 May;50(5):624-642. doi: 10.1002/eji.201847811.
7
Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.金属纳米材料:免疫效应及理化性质对变应性疾病致敏、激发和加重的影响。
J Immunotoxicol. 2019 Dec;16(1):87-124. doi: 10.1080/1547691X.2019.1605553.
8
Epigenome-wide effects of vitamin D on asthma bronchial epithelial cells.维生素 D 对哮喘支气管上皮细胞的全基因组表观遗传效应。
Epigenetics. 2019 Sep;14(9):844-849. doi: 10.1080/15592294.2019.1622993. Epub 2019 Jun 3.
9
Lipophilic Allergens, Different Modes of Allergen-Lipid Interaction and Their Impact on Asthma and Allergy.亲脂性过敏原、过敏原-脂质相互作用的不同模式及其对哮喘和过敏的影响。
Front Immunol. 2019 Feb 14;10:122. doi: 10.3389/fimmu.2019.00122. eCollection 2019.
10
Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β.人表面活性蛋白 D 通过下调 TGF-β 抑制胰腺癌细胞的上皮-间质转化。
Front Immunol. 2018 Aug 15;9:1844. doi: 10.3389/fimmu.2018.01844. eCollection 2018.